Crestline Management’s Concentrix CNXC Stock Holding History

Crestline Management’s Portfolio CNXC Stock Details CNXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-7,159	Closed	-$310K	–	132
2024 Q4	$310K	Buy	+7,159	New	+$318K	0.01%	613

Other funds holding CNXC

GBL

Groupe Bruxelles Lambert Brussels, Belgium $62.2M AUM 57.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Crestline Management's CNXC Position: Q1 2025 in Review

Crestline Management sold out of Concentrix (CNXC) in Q1 2025, closing a stake of 7,159 shares — an estimated $310K sold.

Crestline Management first reported a position in CNXC in Q4 2024 and held it in 1 quarter. The position peaked at $310K in Q4 2024. 346 funds tracked by Wall St. Rank hold CNXC as of Q1 2025.

Crestline Management reported no remaining Concentrix position as of Q1 2025 after selling out during the quarter.
Crestline Management sold 7,159 Concentrix shares in Q1 2025, an estimated $310K.
Crestline Management first reported a position in Concentrix in Q4 2024 and held it in 1 quarter.
Crestline Management's Concentrix position peaked at $310K in Q4 2024.
346 funds tracked by Wall St. Rank held Concentrix as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.